Depending on the postoperative risk stratification of the individual patient:
The primary goal of postoperative administration of RAI after total thyroidectomy may include:
RAI remnant ablation:
To facilitate detection of recurrent disease and initial staging by tests such as Tg measurements or whole-body RAI scans)
RAI adjuvant therapy:
Intended to improve disease-free survival by theoretically destroying suspected, but unproven residual disease, es- pecially in patients at increased risk of disease recurrence)
RAI therapy:
Intended to improve disease-specific and disease-free survival by treating persistent disease in higher risk patients)
Additional considerations in RAI decision-making may include:
Patient comorbidities (and the potential impact of therapeutic doses of RAI or preparation for the procedure)
Feasible or preferred disease surveillance procedures
Patient preferences:
The latter being particularly important when clear data on therapeutic efficacy are lacking), or others
My name is Rodrigo Arrangoiz I am a breast surgeon/ thyroid surgeon / parathyroid surgeon / head and neck surgeon / surgical oncologist that works at Center for Advanced Surgical Oncology in Miami, Florida.
I was trained as a surgeon at Michigan State University from (2005 to 2010) where I was a chief resident in 2010. My surgical oncology and head and neck training was performed at the Fox Chase Cancer Center in Philadelphia from 2010 to 2012. At the same time I underwent a masters in science (Clinical research for health professionals) at the University of Drexel. Through the International Federation of Head and Neck Societies / Memorial Sloan Kettering Cancer Center I performed a two year head and neck surgery and oncology / endocrine fellowship that ended in 2016.
Mi nombre es Rodrigo Arrangoiz, soy cirujano oncólogo / cirujano de tumores de cabeza y cuello / cirujano endocrino que trabaja Center for Advanced Surgical Oncology en Miami, Florida.
Fui entrenado como cirujano en Michigan State University (2005 a 2010 ) donde fui jefe de residentes en 2010. Mi formación en oncología quirúrgica y e n tumores de cabeza y cuello se realizó en el Fox Chase Cancer Center en Filadelfia de 2010 a 2012. Al mismo tiempo, me sometí a una maestría en ciencias (investigación clínica para profesionales de la salud) en la Universidad de Drexel. A través de la Federación Internacional de Sociedades de Cabeza y Cuello / Memorial Sloan Kettering Cancer Center realicé una sub especialidad en cirugía de cabeza y cuello / cirugia endocrina de dos años que terminó en 2016.
View all posts by Rodrigo Arrangoiz MS, MD, FACS, FSSO
Rodrigo Arrangoiz MS, MD, FACS, FSSO 